Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

EPC vs CHD vs PG vs CL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
EPC
Edgewell Personal Care Company

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$1.01B
5Y Perf.-28.8%
CHD
Church & Dwight Co., Inc.

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$22.24B
5Y Perf.+25.1%
PG
The Procter & Gamble Company

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$341.30B
5Y Perf.+26.0%
CL
Colgate-Palmolive Company

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$70.09B
5Y Perf.+20.8%

EPC vs CHD vs PG vs CL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
EPC logoEPC
CHD logoCHD
PG logoPG
CL logoCL
IndustryHousehold & Personal ProductsHousehold & Personal ProductsHousehold & Personal ProductsHousehold & Personal Products
Market Cap$1.01B$22.24B$341.30B$70.09B
Revenue (TTM)$2.11B$6.21B$86.72B$20.38B
Net Income (TTM)$-78M$733M$12.72B$2.13B
Gross Margin40.6%45.1%50.3%60.1%
Operating Margin1.7%17.3%23.2%21.3%
Forward P/E11.4x25.0x21.1x22.9x
Total Debt$1.54B$2.21B$35.46B$7.99B
Cash & Equiv.$226M$409M$9.56B$1.29B

EPC vs CHD vs PG vs CLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

EPC
CHD
PG
CL
StockMay 20May 26Return
Edgewell Personal C… (EPC)10071.2-28.8%
Church & Dwight Co.… (CHD)100125.1+25.1%
The Procter & Gambl… (PG)100126.0+26.0%
Colgate-Palmolive C… (CL)100120.8+20.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: EPC vs CHD vs PG vs CL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: EPC and CHD are tied at the top with 2 categories each — the right choice depends on your priorities. Church & Dwight Co., Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. PG and CL also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
EPC
Edgewell Personal Care Company
The Defensive Pick

EPC has the current edge in this matchup, primarily because of its strength in defensive.

  • Beta 0.79, yield 2.8%, current ratio 1.76x
  • Lower P/E (11.4x vs 21.1x)
  • 2.8% yield, 2-year raise streak, vs PG's 2.8%
Best for: defensive
CHD
Church & Dwight Co., Inc.
The Growth Play

CHD is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.

  • Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
  • Lower volatility, beta 0.14, Low D/E 55.1%, current ratio 1.07x
  • 1.6% revenue growth vs EPC's -1.3%
  • +3.4% vs EPC's -17.6%
Best for: growth exposure and sleep-well-at-night
PG
The Procter & Gamble Company
The Income Pick

PG is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 36 yrs, beta 0.10, yield 2.8%
  • 119.3% 10Y total return vs CHD's 113.6%
  • 14.7% margin vs EPC's -3.7%
  • Beta 0.10 vs EPC's 0.79, lower leverage
Best for: income & stability and long-term compounding
CL
Colgate-Palmolive Company
The Niche Pick

CL is the clearest fit if your priority is efficiency.

  • 12.5% ROA vs EPC's -2.1%, ROIC 43.4% vs 2.6%
Best for: efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthCHD logoCHD1.6% revenue growth vs EPC's -1.3%
ValueEPC logoEPCLower P/E (11.4x vs 21.1x)
Quality / MarginsPG logoPG14.7% margin vs EPC's -3.7%
Stability / SafetyPG logoPGBeta 0.10 vs EPC's 0.79, lower leverage
DividendsEPC logoEPC2.8% yield, 2-year raise streak, vs PG's 2.8%
Momentum (1Y)CHD logoCHD+3.4% vs EPC's -17.6%
Efficiency (ROA)CL logoCL12.5% ROA vs EPC's -2.1%, ROIC 43.4% vs 2.6%

EPC vs CHD vs PG vs CL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

EPCEdgewell Personal Care Company
FY 2025
Razors and blades
49.7%$1.1B
Sun care products
20.6%$459M
Tampons, Pads and Liners
11.8%$262M
Infant Care and Other Products
9.0%$201M
Shaving gels and creams
5.1%$114M
Wipes and other skin care products
3.8%$84M
CHDChurch & Dwight Co., Inc.
FY 2025
Specialty Products Division
100.0%$299M
PGThe Procter & Gamble Company
FY 2025
Fabric Care And Home Care Segment Member
35.5%$29.6B
Baby, Feminine and Family Care Segment Member
24.3%$20.2B
Beauty Segment
17.9%$15.0B
Health Care Segment Member
14.4%$12.0B
Grooming Segment Member
8.0%$6.7B
CLColgate-Palmolive Company
FY 2025
Oral, Personal and Home Care
77.4%$15.8B
Pet Nutrition
22.6%$4.6B

EPC vs CHD vs PG vs CL — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEPCLAGGINGCHD

Income & Cash Flow (Last 12 Months)

PG leads this category, winning 4 of 6 comparable metrics.

PG is the larger business by revenue, generating $86.7B annually — 41.2x EPC's $2.1B. PG is the more profitable business, keeping 14.7% of every revenue dollar as net income compared to EPC's -3.7%. On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricEPC logoEPCEdgewell Personal…CHD logoCHDChurch & Dwight C…PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…
RevenueTrailing 12 months$2.1B$6.2B$86.7B$20.4B
EBITDAEarnings before interest/tax$80M$1.3B$21.9B$3.9B
Net IncomeAfter-tax profit-$78M$733M$12.7B$2.1B
Free Cash FlowCash after capex$49M$1.1B$15.0B$3.6B
Gross MarginGross profit ÷ Revenue+40.6%+45.1%+50.3%+60.1%
Operating MarginEBIT ÷ Revenue+1.7%+17.3%+23.2%+21.3%
Net MarginNet income ÷ Revenue-3.7%+11.8%+14.7%+10.5%
FCF MarginFCF ÷ Revenue+2.3%+17.2%+17.3%+17.8%
Rev. Growth (YoY)Latest quarter vs prior year-10.5%+0.1%+7.4%+5.8%
EPS Growth (YoY)Latest quarter vs prior year-136.7%+2.2%+5.8%-105.1%
PG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

EPC leads this category, winning 4 of 6 comparable metrics.

At 22.4x trailing earnings, PG trades at a 45% valuation discount to EPC's 40.8x P/E. On an enterprise value basis, EPC's 12.6x EV/EBITDA is more attractive than CHD's 18.1x.

MetricEPC logoEPCEdgewell Personal…CHD logoCHDChurch & Dwight C…PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…
Market CapShares × price$1.0B$22.2B$341.3B$70.1B
Enterprise ValueMkt cap + debt − cash$2.3B$24.0B$367.2B$76.8B
Trailing P/EPrice ÷ TTM EPS40.84x31.09x22.44x33.22x
Forward P/EPrice ÷ next-FY EPS est.11.41x25.01x21.14x22.88x
PEG RatioP/E ÷ EPS growth rate4.01x
EV / EBITDAEnterprise value multiple12.56x18.14x15.76x15.43x
Price / SalesMarket cap ÷ Revenue0.45x3.59x4.05x3.44x
Price / BookPrice ÷ Book value/share0.66x5.73x6.86x194.13x
Price / FCFMarket cap ÷ FCF24.42x20.35x24.30x19.29x
EPC leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

CL leads this category, winning 4 of 9 comparable metrics.

CL delivers a 2.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-5 for EPC. CHD carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to CL's 21.88x. On the Piotroski fundamental quality scale (0–9), CHD scores 7/9 vs PG's 5/9, reflecting strong financial health.

MetricEPC logoEPCEdgewell Personal…CHD logoCHDChurch & Dwight C…PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…
ROE (TTM)Return on equity-5.1%+17.4%+23.8%+2.5%
ROA (TTM)Return on assets-2.1%+8.2%+10.0%+12.5%
ROICReturn on invested capital+2.6%+13.9%+20.1%+43.4%
ROCEReturn on capital employed+3.0%+14.4%+23.0%+41.6%
Piotroski ScoreFundamental quality 0–95756
Debt / EquityFinancial leverage0.99x0.55x0.68x21.88x
Net DebtTotal debt minus cash$1.3B$1.8B$25.9B$6.7B
Cash & Equiv.Liquid assets$226M$409M$9.6B$1.3B
Total DebtShort + long-term debt$1.5B$2.2B$35.5B$8.0B
Interest CoverageEBIT ÷ Interest expense0.01x15.59x487.21x12.37x
CL leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — PG and CL each lead in 2 of 6 comparable metrics.

A $10,000 investment in PG five years ago would be worth $12,240 today (with dividends reinvested), compared to $5,654 for EPC. Over the past 12 months, CHD leads with a +3.4% total return vs EPC's -17.6%. The 3-year compound annual growth rate (CAGR) favors CL at 5.0% vs EPC's -18.4% — a key indicator of consistent wealth creation.

MetricEPC logoEPCEdgewell Personal…CHD logoCHDChurch & Dwight C…PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…
YTD ReturnYear-to-date+29.3%+14.0%+4.5%+13.8%
1-Year ReturnPast 12 months-17.6%+3.4%-5.6%-1.6%
3-Year ReturnCumulative with dividends-45.6%+0.7%+1.9%+15.7%
5-Year ReturnCumulative with dividends-43.5%+13.7%+22.4%+18.2%
10-Year ReturnCumulative with dividends-68.2%+113.6%+119.3%+47.0%
CAGR (3Y)Annualised 3-year return-18.4%+0.2%+0.6%+5.0%
Evenly matched — PG and CL each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CHD and CL each lead in 1 of 2 comparable metrics.

CL is the less volatile stock with a -0.00 beta — it tends to amplify market swings less than EPC's 0.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.5% from its 52-week high vs EPC's 74.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricEPC logoEPCEdgewell Personal…CHD logoCHDChurch & Dwight C…PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…
Beta (5Y)Sensitivity to S&P 5000.79x0.14x0.10x-0.00x
52-Week HighHighest price in past year$28.92$106.04$170.99$99.33
52-Week LowLowest price in past year$15.88$81.33$137.62$74.55
% of 52W HighCurrent price vs 52-week peak+74.8%+88.5%+85.4%+87.9%
RSI (14)Momentum oscillator 0–10051.249.153.758.1
Avg Volume (50D)Average daily shares traded662K1.8M7.2M5.6M
Evenly matched — CHD and CL each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — EPC and PG each lead in 1 of 2 comparable metrics.

Analyst consensus: EPC as "Hold", CHD as "Buy", PG as "Buy", CL as "Hold". Consensus price targets imply 10.8% upside for PG (target: $162) vs 6.1% for CHD (target: $100). For income investors, EPC offers the higher dividend yield at 2.84% vs CHD's 1.25%.

MetricEPC logoEPCEdgewell Personal…CHD logoCHDChurch & Dwight C…PG logoPGThe Procter & Gam…CL logoCLColgate-Palmolive…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$23.67$99.60$161.88$93.70
# AnalystsCovering analysts17345245
Dividend YieldAnnual dividend ÷ price+2.8%+1.3%+2.8%+2.6%
Dividend StreakConsecutive years of raises223365
Dividend / ShareAnnual DPS$0.62$1.18$4.02$2.25
Buyback YieldShare repurchases ÷ mkt cap+8.9%+4.0%+1.9%+1.7%
Evenly matched — EPC and PG each lead in 1 of 2 comparable metrics.
Key Takeaway

PG leads in 1 of 6 categories (Income & Cash Flow). EPC leads in 1 (Valuation Metrics). 3 tied.

Best OverallEdgewell Personal Care Comp… (EPC)Leads 1 of 6 categories
Loading custom metrics...

EPC vs CHD vs PG vs CL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is EPC or CHD or PG or CL a better buy right now?

For growth investors, Church & Dwight Co.

, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -1. 3% for Edgewell Personal Care Company (EPC). The Procter & Gamble Company (PG) offers the better valuation at 22. 4x trailing P/E (21. 1x forward), making it the more compelling value choice. Analysts rate Church & Dwight Co. , Inc. (CHD) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — EPC or CHD or PG or CL?

On trailing P/E, The Procter & Gamble Company (PG) is the cheapest at 22.

4x versus Edgewell Personal Care Company at 40. 8x. On forward P/E, Edgewell Personal Care Company is actually cheaper at 11. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — EPC or CHD or PG or CL?

Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +22.

4%, compared to -43. 5% for Edgewell Personal Care Company (EPC). Over 10 years, the gap is even starker: PG returned +119. 3% versus EPC's -68. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — EPC or CHD or PG or CL?

By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at -0.

00β versus Edgewell Personal Care Company's 0. 79β — meaning EPC is approximately -18107% more volatile than CL relative to the S&P 500. On balance sheet safety, Church & Dwight Co. , Inc. (CHD) carries a lower debt/equity ratio of 55% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — EPC or CHD or PG or CL?

By revenue growth (latest reported year), Church & Dwight Co.

, Inc. (CHD) is pulling ahead at 1. 6% versus -1. 3% for Edgewell Personal Care Company (EPC). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to -73. 1% for Edgewell Personal Care Company. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — EPC or CHD or PG or CL?

The Procter & Gamble Company (PG) is the more profitable company, earning 19.

0% net margin versus 1. 1% for Edgewell Personal Care Company — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 4. 3% for EPC. At the gross margin level — before operating expenses — CL leads at 60. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is EPC or CHD or PG or CL more undervalued right now?

On forward earnings alone, Edgewell Personal Care Company (EPC) trades at 11.

4x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 13. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 10. 8% to $161. 88.

08

Which pays a better dividend — EPC or CHD or PG or CL?

All stocks in this comparison pay dividends.

Edgewell Personal Care Company (EPC) offers the highest yield at 2. 8%, versus 1. 3% for Church & Dwight Co. , Inc. (CHD).

09

Is EPC or CHD or PG or CL better for a retirement portfolio?

For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

00), 2. 6% yield). Both have compounded well over 10 years (CL: +47. 0%, EPC: -68. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between EPC and CHD and PG and CL?

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

EPC

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Gross Margin > 24%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

CHD

Stable Dividend Mega-Cap

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

PG

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

CL

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform EPC and CHD and PG and CL on the metrics below

Revenue Growth>
%
(EPC: -10.5% · CHD: 0.1%)
P/E Ratio<
x
(EPC: 40.8x · CHD: 31.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.